Latest News and Press Releases

PetMed delayed its Q4 and FY2025 earnings release to complete its year-end audit, causing the stock to fall 11.22% to $3.72 on June 11, 2025.

PetMed delayed its year-end earnings release to complete its audit, and the stock fell 11% to $3.72 per share following the announcement.

PetMed allegedly misled investors; delayed FY25 earnings release for audit issues, triggering 11% stock drop on June 11, 2025.

Block & Leviton LLP is investigating PetMed Express (NASDAQ: PETS) for securities fraud. Investors who have lost money in PetMeds should contact the firm.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PetMed (PETS), GeneDx (WGS), Lineage (LINE), or Proficient Auto (PAL) To Contact Him...

Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, June 24, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PetMed Express, Inc. (“PetMed”...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 14, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PetMed Express, Inc. (“PetMed”...

NEW YORK, Oct. 05, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of PetMed Express, Inc. (NASDAQ:PETS) from May 8, 2017 through...

NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of PetMed...

OKLAHOMA CITY, Aug. 29, 2017 (GLOBE NEWSWIRE) -- Federman & Sherwood announces that on August 25, 2017, a class action lawsuit was filed in the United States District Court for the Southern...